Edition:
United States

Profile: Consort Medical PLC (CSRT.L)

CSRT.L on London Stock Exchange

1,072.00GBp
18 Aug 2017
Change (% chg)

-17.00 (-1.56%)
Prev Close
1,089.00
Open
1,088.00
Day's High
1,095.00
Day's Low
1,072.00
Volume
4,006
Avg. Vol
28,115
52-wk High
1,180.00
52-wk Low
960.00

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Company Address

Consort Medical PLC

Ste D, Breakspear Park, Breakspe
HEMEL HEMPSTEAD     HP2 4TZ
P: +441442.867920
F: +441442.245237

Company Web Links